Advanced therapy medicinal products (cell, gene, tissue-based)
Advanced Therapy Medicinal Products (ATMPs) include gene therapies, cell-based therapies, and tissue-engineered products.
They represent a breakthrough in modern medicine by providing targeted solutions for rare and severe diseases.
Their development is strictly regulated under European law to ensure safety and quality. As these therapies emerge, there is increasing need for robust clinical data collection and post-marketing surveillance to confirm their long-term efficacy and safety in real-world settings.
